Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology

Resistance to programmed cell death (PCD) is a hallmark of cancer. While some PCD components are prognostic in cancer, the roles of many molecules can be masked by redundancies and crosstalks between PCD pathways, impeding the development of targeted therapeutics. Recent studies characterizing these...

Descripción completa

Detalles Bibliográficos
Autores principales: Mall, Raghvendra, Bynigeri, Ratnakar R, Karki, Rajendra, Malireddi, R K Subbarao, Sharma, Bhesh Raj, Kanneganti, Thirumala-Devi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Cancer Computational Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623737/
https://www.ncbi.nlm.nih.gov/pubmed/36329783
http://dx.doi.org/10.1093/narcan/zcac033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623737/
https://www.ncbi.nlm.nih.gov/pubmed/36329783
http://dx.doi.org/10.1093/narcan/zcac033

Ejemplares similares